Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds

Endocrinology

Volumn 142, Issue 11, 2001, Pages 4937-4945

  Bonnette, Sharon G ^a   Hadsell, Darryl L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CELL; BREAST DEVELOPMENT; BREAST DUCT; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; TISSUE TRANSPLANTATION;

EID: 0034748607     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.11.8500     Document Type: Article

References (45)

1. Mammary ductal elongation: Differentiation of myoepithelium and basal lamina during branching morphogenesis
2. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis
3. Cell types and morphogenesis in the mammary gland
4. Programmed cell death in the terminal endbud
5. Apoptosis in the terminal endbud of the murine mammary gland: A mechanism of ductal morphogenesis
6. Early mammary development: Growth hormone and IGF-1
7. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: Sites of messenger ribonucleic acid expression and potential functions
8. Role of IGF-I in normal mammary development
9. Targeted expression of des (1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression
10. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis
11. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development
12. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development
13. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-achvated protein kinase pathways
14. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
15. Dual control of cell growth by somatomedins and platelet-derived growth factor
16. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor
17. Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
18. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of β-catenin
19. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model
20. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice
21. The role of the IGF-1 receptor in apoptosis
22. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling
23. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
24. Insulin receptors in breast cancer
25. Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification
26. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
27. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (igf1r)
28. Rescue of mammary epithelium of early lethal phenotypes by embryonic mammary gland transplantation as exemplified with insulin receptor null mice
29. IGF and insulin action in the mammary gland: Lessons from transgenic and knockout models
30. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice
31. Morphological and functional properties of TM preneoplastic mammary outgrowths
32. The development of the terminal end bud in the prepubertal-pubertal mouse mammary gland
33. Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules
34. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity
35. Epithelial cell types and their evolution in the rat mammary gland determined by immunological markers
36. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice
37. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
38. Functional release of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b
39. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
40. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor
41. Changes in the kinase activity of the insulin receptor account for an increased insulin sensitivity of mammary gland in late pregnancy
42. Changes in insulin responsiveness during development of mammary epithelium
43. Role of insulin-like growth factors in embryonic and postnatal growth
44. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
45. Apoptosis and the cell cycle